NAUTILUS BIOTECHNOLOGY INC's ticker is NAUT and the CUSIP is 63909J108. A total of 83 filers reported holding NAUTILUS BIOTECHNOLOGY INC in Q4 2021. The put-call ratio across all filers is 0.71 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $521,721 | -62.4% | 289,845 | -55.8% | 0.03% | -62.2% |
Q3 2022 | $1,389,000 | -34.2% | 655,338 | -16.5% | 0.09% | -15.1% |
Q2 2022 | $2,111,000 | -45.6% | 784,798 | -12.2% | 0.11% | -38.4% |
Q1 2022 | $3,878,000 | -27.3% | 893,561 | -13.2% | 0.17% | -8.5% |
Q4 2021 | $5,335,000 | -16.8% | 1,029,872 | -1.4% | 0.19% | -6.9% |
Q3 2021 | $6,412,000 | -46.7% | 1,044,267 | -12.3% | 0.20% | -40.9% |
Q2 2021 | $12,027,000 | – | 1,190,810 | – | 0.34% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Madrona Venture Group, LLC | 6,020,770 | $30,663,000 | 4.08% |
Ally Bridge Group (NY) LLC | 1,500,000 | $9,210,000 | 2.71% |
AMAZON COM INC | 1,457,055 | $8,946,000 | 1.82% |
Affinity Asset Advisors, LLC | 975,000 | $5,987,000 | 1.51% |
Tikvah Management LLC | 708,540 | $4,350,436,000 | 1.18% |
Perceptive Advisors | 8,911,151 | $54,714,000 | 0.80% |
Bain Capital Life Sciences Investors, LLC | 2,000,000 | $12,280,000 | 0.76% |
HILLMAN CO | 200,000 | $1,228,000 | 0.43% |
SPHERA FUNDS MANAGEMENT LTD. | 800,000 | $4,912,000 | 0.41% |
RA Capital Management | 2,436,430 | $14,960,000 | 0.21% |